Consequences in infants that were intrauterine growth restricted

Erich Cosmi1, Tiziana Fanelli, Silvia Visentin

  • 1Department of Gynecological Science and Human Reproduction, Maternal Fetal Medicine Unit, School of Medicine, University of Padua, Padua 35128, Italy. ecosmi@hotmail.com

Insights

Intrauterine growth restriction (IUGR) hinders fetal growth, increasing risks of poor perinatal outcomes. Prompt antenatal surveillance and infant follow-up are crucial for managing IUGR and its consequences.

Area of Science:

  • Obstetrics and Gynecology
  • Fetal Medicine
  • Neonatology

Background:

  • Intrauterine growth restriction (IUGR) is a significant concern, impacting fetal development and leading to adverse perinatal outcomes.
  • Placental insufficiency is a primary cause of IUGR, often resulting in fetal cardiovascular abnormalities.

Purpose of the Study:

  • To highlight the implications of intrauterine growth restriction on fetal development.
  • To emphasize the necessity of vigilant antenatal surveillance and postnatal follow-up for affected infants.

Main Methods:

  • This abstract discusses the condition of intrauterine growth restriction.
  • It reviews the etiological link between placental insufficiency and fetal cardiovascular issues.
  • It underscores the importance of monitoring and follow-up protocols.

Main Results:

  • Intrauterine growth restriction (IUGR) is characterized by a fetus not reaching its growth potential.
  • IUGR is associated with increased perinatal morbidity and mortality.
  • Placental insufficiency leading to IUGR causes fetal cardiovascular abnormalities.

Conclusions:

  • Intrauterine growth restriction necessitates intensive antenatal surveillance.
  • Postnatal follow-up is essential to address short- and long-term sequelae in infants with IUGR.
  • Early detection and management of IUGR can mitigate adverse outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
694
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.0K